Get in touch
Who we are
MS Pen Technologies
is empowering researchers, surgeons and clinicians with molecular data at the point of need to drive better outcomes for patients.
We envision a future where molecular
data can be used at the point of need to
better serve patients
In the news
The world is taking notice
Medical 'Pen' can detect cancer in 10 seconds
2023 Finalists MS Pen Technologies, Inc. MasSpec Pen
This pen can diagnose cancer in 10 seconds
MacArthur ‘Genius Grant’ Winner Includes Inventor of MasSpec Pen
This pen diagnoses cancer mid-surgery in seconds
‘Cancer Pen’ Lets Docs Spot Tumor Cells in Seconds
Cancer pen could detect tumors during surgery in seconds
‘Pen’ identifies cancer in 10 seconds
Handheld MasSpec Pen for molecular cancer detection during surgeries
Breakthrough Medical Technologies So Crazy They Sound like Science fiction
Justin Wiseman, PhD
CEO & Board Dir.
Entrepreneur, Inventor, Former President & CEO of Prosolia, Inc.
Led acquisition of Prosolia by Waters, Corp.
Distinguished Science Alumni Entrepreneur, Purdue University
Livia Eberlin, PhD
Co-founder, CSO, Board Dir.
Associate Professor, Michael E. DeBakey Department of Surgery
Director, INSTINCT Surgical Technology & Innovation Center
MacArthur Fellow, “Genius Grant” recipient
Forbes 30 under 30 in medicine
James Suliburk, MD
Co-founder, CMO, Board Dir.
Chief of Endocrine Surgery and Professor of Surgery at Baylor College of Medicine
TS Reeve International Fellow in Endocrine Surgery
Get in touch
Copyright © 2023 MS Pen Technologies, Inc. All rights reserved.
Research use only. Not for use in diagnostic procedures.